Life Sciences & Healthcare Innovation Program – Previously Recorded
Biosimilars: Lessons Learned 10 Years After Enactment of the Biologics Price Competition and Innovation Act (BPCIA)
Event summary
This webinar will discuss
- A recap of the key provisions of the BPCIA statute and an explanation of biosimilars’ path to the marketplace
- How biosimilars introduced pursuant to the BPCIA have impacted (or failed to impact) the marketplace for biologic drugs
- How BPCIA court decisions and patent litigation case outcomes have shaped innovator and biosimilar partnering, litigation, and commercialization strategies
This webinar is part of our Life Sciences & Healthcare Innovation Program.
Related contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.